Slide 1

Save The Date!

VPM & TWINCORE Joint Symposium | Sep 15-16, 2022 | Hannover

This year the 14th TWINCORE Symposium and the 13th International VPM Days, celebrating VPM's 20th Anniversary, have taken place as a joint symposium "Lessons from the pandemic for future infection research" on Thursday and Friday, 15 and 16 September 2022 in Hannover, Germany.

Press

Results of SAKK 06/14 trial with VPM1002BC

Slide 2

SAVE THE DATE!

VPM & TWINCORE Joint Symposium | Sep 15-16, 2022 | Hannover

Press

Results of SAKK 06/14 trial with VPM1002BC

The phase I/II clinical trial data with VPM1002BC, a genetically modified bacillus Calmette-Guérin (BCG) strain, has been published in European Urology Oncology. Even three years after the treatment start, almost half of the patients remained recurrence-free. We thank all patients, colleagues, and collaborators for their contributions.

Slide 3

A competent partner at your side

Free first consulting session

We understand how complexe product development is, because we did it ourselves. Let us be a competent partner at your side for a secure route to a successful product.

From Bench to Product

Consulting and services

Slide 4

A competent partner at your side

Free first consulting session

From Bench to Product

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

previous arrowprevious arrow
next arrownext arrow

About Vakzine Projekt Management

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.

The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.

News & Press

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our Method

Translational project management from the laboratory bench to clinical development.

Scroll to Top